CareDx (CDNA) Reports Q3 EPS of $0.12

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to CareDx (CDNA) Reports Q3 EPS of $0.12

CareDx, Inc. Reports Third Quarter 2014 Financial Results

November 10, 2014 4:05 PM EST

BRISBANE, Calif., Nov. 10, 2014 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value, non-invasive surveillance solutions for transplant recipients, today reported financial results for the three and nine months ended September 30, 2014.

Recent Highlights:

Third quarter revenues reached $6.7 million, an increase of 15% over the same period in 2013 Third quarter net income was $1.2 million and basic and diluted net income per share were $0.13 and $0.12, respectively. Net income was driven in part by changes in accounting estimates and one-time events.... More